Relapse-free survival is significantly better for patients younger than age 55.

P = .012. Figure shows estimated distributions of relapse-free survival (Kaplan-Meier estimates) from date of complete response, by age at start of initial therapy. Tick marks indicate patients who were alive without report of relapse at last contact.